The inflammatory effects of UDP-glucose in N9 microglia are not mediated by P2Y14 receptor activation
Open Access
- 8 February 2008
- journal article
- research article
- Published by Springer Nature in Purinergic Signalling
- Vol. 4 (1) , 73-78
- https://doi.org/10.1007/s11302-008-9095-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Functional expression of the P2Y14 receptor in human neutrophilsEuropean Journal of Pharmacology, 2006
- Neurons and glial cells differentially express P2Y receptor mRNAs in the rat dorsal root ganglion and spinal cordJournal of Comparative Neurology, 2006
- Pharmacological profiles of cloned mammalian P2Y-receptor subtypesPharmacology & Therapeutics, 2006
- Functional expression of the P2Y14 receptor in murine T‐lymphocytesBritish Journal of Pharmacology, 2005
- Purinergic receptor modulation of BV-2 microglial cell activity: Potential involvement of p38 MAP kinase and CREBJournal of Neuroimmunology, 2005
- Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expressionPharmacological Research, 2005
- Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitroEuropean Journal of Neuroscience, 2003
- Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor familyTrends in Pharmacological Sciences, 2003
- Monokine production by microglial cell clonesEuropean Journal of Immunology, 1989
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970